WHO halts hydroxychloroquine test trial despite a new study showing the drug made patients 50%…

Read more on this subject: Drugs and Medications
News Story Source: https://www.dailymail.co, By LAUREN EDMONDS
The World Health Organization on Saturday announced that it was ending a trial of the malaria drug hydroxychloroquine – widely touted by President Trump as a miracle drug – despite a new study finding it made coronavirus patients 50 per cent less likely to die.

WHO said in a press release that it has 'accepted the recommendation' from The International Steering Committee to discontinue the trial for hydroxychloroquine, as well as HIV/AIDS medications lopinavir and ritonavir, because it failed to reduce COVID-19 mortality. 

The drugs were being compared with standard care for hospitalized patients. 

'These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care,' a press release read. 

'Solidarity trial investigators will interrupt the trials with immediate effect,' the WHO said in a statement,
Read More or Make a Comment

Bookmark the permalink.

Comments are closed.